Vascular Dementia

This disorder is though to occur from repeated “mini-strokes” that occur over an extended period of time that results in the destruction of the micro-vasculature in the brain. Presently, there is no treatment to enhance the regeneration of blood vessels in the brain that could assist in these patients' recovery. Zhittya Genesis Medicine's management believes several hundred thousand patients suffering from vascular dementia could benefit from its angiogenesis drug to enhance blood flow within their brains, allowing increase function and cognitive abilities. This is an unmet medical need, and Zhittya's management believes a drug to treat vascular dementia would qualify for a breakthrough therapy designation by the FDA.